Insider Transactions in Q1 2023 at Inovio Pharmaceuticals, Inc. (INO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
5,833
-0.64%
|
$5,833
$1.15 P/Share
|
|
Mar 11
2023
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,666
+1.26%
|
-
|
|
Mar 11
2023
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,410
-11.7%
|
$31,410
$1.13 P/Share
|
|
Mar 11
2023
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
59,737
+18.2%
|
-
|
|
Mar 11
2023
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,980
-13.91%
|
$25,980
$1.13 P/Share
|
|
Mar 11
2023
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,737
+24.23%
|
-
|
|
Mar 11
2023
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,658
-8.78%
|
$20,658
$1.13 P/Share
|
|
Mar 11
2023
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,737
+20.25%
|
-
|
|
Feb 27
2023
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
11,668
-1.27%
|
$11,668
$1.28 P/Share
|
|
Feb 26
2023
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,937
-7.74%
|
$27,937
$1.28 P/Share
|
|
Feb 26
2023
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,811
+15.88%
|
-
|
|
Feb 26
2023
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
41,123
-9.15%
|
$41,123
$1.28 P/Share
|
|
Feb 26
2023
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
70,511
+13.44%
|
-
|
|
Feb 26
2023
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
42,273
-15.12%
|
$42,273
$1.28 P/Share
|
|
Feb 26
2023
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
92,778
+24.55%
|
-
|
|
Feb 26
2023
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,334
+1.27%
|
-
|
|
Jan 15
2023
|
Jay Shepard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,273
+9.76%
|
-
|